Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | Sr VP Rsch & Preclinical Dev | November 12, 2004 | November 16, 2004 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date November 12, 2004 · Filed November 16, 2004
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 22,500 |
Reported balance
After 2004-11-12 transaction · row 1
1 source rowRow 1 · 2004-11-12 · Sale · Disposed 3,213 · Balance 22,500 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 12, 2004 Filed Nov 16, 2004 01:05 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 3,213 | $60.01 | $192,804.42 |
DisclosureSEC source: 0001181431-04-052959 · rrd58067.xml · nonDerivative · entry 1 MILETICH JOSEPH P · CIK 0001184125 · Sr VP Rsch & Preclinical Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Read SEC document |
| April 01, 2004 Filed Apr 2, 2004 19:39 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,787 | $58.64 | $104,789.68 |
DisclosureSEC source: 0001181431-04-018955 · rrd38585.xml · nonDerivative · entry 1 MILETICH JOSEPH P · CIK 0001184125 · Sr VP Rsch & Preclinical Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,713 Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 22:34 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 48,319 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-015974 · rrd36855.xml · derivative · entry 2 MILETICH JOSEPH P · CIK 0001184125 · Sr VP Rsch & Preclinical Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,319 Underlying: Common Stock · 48,319 shares Expires 2011-03-15 F1 · derivative.exercise_date: (3.15.04) The option becomes exercisable in five as nearly equal annual installments as possible, beginning on March 15, 2005. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 22:34 UTC | AMGEN INC AMGN · Entity 2832 | GrantISO (Right to Buy) · Derivative | 1,681 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-015974 · rrd36855.xml · derivative · entry 1 MILETICH JOSEPH P · CIK 0001184125 · Sr VP Rsch & Preclinical Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,681 Underlying: Common Stock · 1,681 shares Expires 2011-03-15 Read SEC document |
| July 01, 2003 Filed Jul 2, 2003 20:25 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 98,482 | $0.00 Strike: $65.85 | $0.00 |
DisclosureSEC source: 0001181431-03-012811 · rrd11636.xml · derivative · entry 2 MILETICH JOSEPH P · CIK 0001184125 · Sr VP Rsch & Preclinical Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,482 Underlying: Common Stock · 98,482 shares Expires 2010-07-01 F2 · price: 0 F1 · derivative.exercise_date: (JPM-07/03-NQSO) The option becomes exercisable for 20,000 shares on July 1, 2004; 20,000 shares on July 1, 2005; 20,000 shares on July 1, 2006; 20,000 shares on July 1, 2007; and 18,482 shares on July 1, 2008, respectively. Read SEC document |
| July 01, 2003 Filed Jul 2, 2003 20:25 UTC | AMGEN INC AMGN · Entity 2832 | GrantISO (Right to Buy) · Derivative | 1,518 | $0.00 Strike: $65.85 | $0.00 |
DisclosureSEC source: 0001181431-03-012811 · rrd11636.xml · derivative · entry 1 MILETICH JOSEPH P · CIK 0001184125 · Sr VP Rsch & Preclinical Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,518 Underlying: Common Stock · 1,518 shares Expires 2010-07-01 F2 · price: 0 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.